Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (1,219,962)	$ 222,136
Adjustments to reconcile net loss to net cash used in operating activities
Gain on conversion of debt	(351,918)
Fair value of options issued in exchange for services	34,093	802,267
Accretion of discount on notes payable	10,447
Change in fair value of warrant liability	(1,286,845)	(2,836,572)
Change in fair value of embedded derivative liability		(600,000)
Fair value of stock in excess of converted notes payable and accrued interest		82,000
Amortization and depreciation	42,943	41,180
Stock and warrants issued in exchange for technology		844,000
Amortization of deferred compensation	6,198
(Increase) decrease in assets
Accounts receivable	(62,125)	(55,148)
Inventory	22,784	(50,013)
Prepaid expenses	2,402	5,263
Increase (decrease) in liabilities
Accounts payable and accrued expenses	2,273,138	116,684
Deferred revenue	(12,500)
Net cash used in operating activities	(541,345)	(1,428,203)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of patents	(100)
Net cash used in investing activities	(100)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of notes payable	159,542	250,000
Proceeds from sale of Series A Convertible Preferred Stock	1,278,501
Proceeds from sale of common stock	50,000
Net cash provided by financing activities	1,488,043	250,000
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	946,598	(1,178,203)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	63,956	1,285,973
CASH AND CASH EQUIVALENTS - END OF PERIOD	1,010,554	107,770
Cash paid during the year for:
Interest	0	0
Income taxes	0	0
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Fair value of stock issued for conversion of notes payable and accrued interest		424,588
Fair value of warrants issued as debt discount		$ 34,222
Cashless exercise of warrants	2
Series A Convertible Preferred Stock converted to common stock	633,333
Issuance of Series A Convertible Preferred Stock for deferred compensation	35,000
Issuance of Series A Convertible Preferred Stock for stockholder notes payable and accrued interest	136,813
Issuance of Series B Convertible Preferred Stock for accrued expenses	$ 6,500,000
Conversion of warrants associated with notes payable	1,867,417
Conversion of warrants to common stock	$ 40,000
Issuance of common stock for notes payable and accrued interest	801,697
Common stock issued for deferred compensation	446,250
Forgiveness of stockholder compensation	$ 175,285